Dr. Paul Baudin, currently completing his medical degree at the Sorbonne Paris Nord university, tells us how his Ph.D. broadened his conceptualization of neurological diseases and treatments, and emphasizes the importance of publishing negative data.

Dr. Kathleen Bryant tells the story of her journey in the alcohol research field and discusses the surprising findings in her recent first author publication from Dr. Jacqueline Barker’s lab at Drexel University, where she obtained her doctoral degree.

Learn how and why eNeuro became a venue to publish and share Open-Source Tools and Methods papers.

Reginald Cannady and Sudarat Nimitvilai-Roberts tell the story about their co-first author paper about time-dependent changes in cellular excitability of neurons in the prefrontal cortex following chronic voluntary ethanol drinking in mice.

Parley Belsey and Eric Yttri tell the story about how they created a highly customizable, low cost and reproducible open-source behavior training platform for studying motor control, decision-making, and reaching reaction time in rodents.

Alexandra Castillo-Ruiz and Nancy Forger tell the story about their eNeuro paper that sheds light on the long-standing question of what controls the timing and magnitude of developmental neuronal cell death.

Omri Nachmani and Gunnar Blohm talk about their paper on how sensorimotor prediction and uncertainty modulate oculomotor tracking behavior, and share their thoughts on publishing through the Registered Report format.

Ramendra Saha tells the story behind his first publication as senior author on histone H2A.Z hypervariant function and the challenges he faced as a new independent investigator.

Munjal Acharya and Charles Limoli discuss new concerns that radiation-induced neurocognitive risks could comprise astronaut safety during NASA’s intended mission to Mars.

Ankan Biswas and Supratim Ray tell the story about their paper that examined whether individuals can better control the power of their EEG-recorded alpha oscillations when provided real-time valid neurofeedback, compared to invalid and neutral neurofeedback.